Dr. Matthew Wheeler is a physician scientist with interests in cardiomyopathies, rare and undiagnosed diseases, therapeutics and genomics. Dr. Wheeler has research training in both myocardial and skeletal muscle biology and genetics, genomics, and multi-scale networks and is a physician with interest and experience treating patients with hypertrophic cardiomyopathy and other inherited cardiomyopathies. I have clinical training in medicine, cardiology, cardiovascular genetics, and advanced heart failure.

Dr. Eran Bendavid's research interests involve understanding the relationship between policies and health outcomes in developing countries. Dr. Bendavid explores how decisions about foreign assistance for health are made, and how those decisions affect health and health delivery systems in recipient countries. He further explores issues of resource allocation in low and middle-income countries through disease modeling and cost-effectiveness analyses.

Dr. Thomas Montine is the Chair of the Department of Pathology at Stanford University.  Dr. Montine is also the founding Director of the Pacific Udall Center and the Neuropathology and Biospecimens Core leader of the Stanford Alzheimer's Disease Center.

Dr. Anand Veeravagu's research efforts are focused on the utilization of large national databases to assess cost, quality, and effectiveness of various treatment alogirthms as well as predictive analytics. Dr. Veeravagu is also an author and writes about current events, health policy, and public health-related topics for the San Francisco Chronicle, The Daily Beast, The BBC, and the Huffington Post.

Dr. Derek Amanatullah specializes in hip and knee replacements for individuals with osteoarthritis, rheumatoid arthritis, infectious arthritis and avascular necrosis. He also performs revision surgeries of knee and hip implants with problems.

Dr. Amanatullah's group works in novel approaches to diagnosing and treating implant associated infections, focusing on antibiotic independent or synergistic methods.

Dr. Adrian Lew's interests lie in the broad area of computational solid mechanics. He is concerned with the fundamental design and mathematical analysis of material models and numerical algorithms.

Currently, Dr. Lew's group is focused on the design of algorithms to simulate hydraulic fracturing. To this end, they work on algorithms for time-integration embedded or immersed boundary methods.

Dr. Carlos Milla's research interests have centered on the inflammatory responses that lead to airway disease in Cystic Fibrosis (CF) and the metabolic factors that contribute to CF lung disease progression. Current efforts are focused on the understanding of the early events that drive the development of lung disease through the study of infants with CF identified by newborn screening. This includes the development of new diagnostic tools that permit the early detection of lung disease manifestations.

Dr.

Dr. Natalie Torok's lab investigates the molecular mechanisms of liver fibrosis,  focusing on the role of oxidative pathways in non-alcoholic and alcoholic steatohepatitis.

Dr. Torok's lab has demonstrated the intricate link between hepatocyte cell death, generation of apoptotic bodies and their phagocytosis by stellate cells triggering fibrogenic activation. Key to this was the activation of the NADPH oxidase and production of reactive oxidative species inducing stellate cell transdifferentiation and collagen I transcription.

Dr. Sohail Husain is a Physician-Scientist in Pediatric Gastroenterology, whose overarching research goal is to come up with targeted therapies for exocrine pancreatic disorders, particularly pancreatitis. Dr. Husain's lab studies three broad areas of the exocrine pancreas: (1) The crucial signaling pathways that initiate and transduce pancreatitis; (2) the factors that turn on pancreatic regeneration and recovery after pancreatic injury; and (3) the mechanisms underlying drug-induced pancreatitis.